Mobile Mindfulness Meditation for Cancer-Related Anxiety and Neuropathy: Protocol for a Randomized Controlled Trial (Preprint)
Ariel Siritorn Orasud, Mai Uchiyama, Ian Pagano, Erin O Bantum
Study at a glance
AI-extracted from the abstract| Characteristics | Randomized waitlist controlled trial |
|---|---|
| Sample size | 400 |
| Population | Cancer survivors who have finished primary treatment and experience anxiety or cancer-related neuropathy |
| Intervention | Mindfulness Coach mobile app |
| Duration | 16 weeks |
| Topics | Anxiety Meditation |
| Registration | NCT03581357 |
| Key findings | This is a protocol paper describing an ongoing trial; no results are reported. The study aims to evaluate the Mindfulness Coach mobile app's impact on anxiety and cancer-related neuropathy, with outcomes expected in early 2024. |
Abstract
Background: Anxiety- and cancer-related neuropathy are two persistent effects related to treatment for cancer. Mindfulness meditation has been used with substantial impact as a nonpharmacologic intervention to mitigate side and late effects of treatment. Mobile apps are ubiquitous for most of the general population, yet have a particular relevance for cancer survivors, given that physical and geographic limitations can be present.
Objective: This study aims to describe an ongoing trial of the Mindfulness Coach mobile app for cancer survivors.
Methods: In this randomized waitlist controlled trial, cancer survivors experiencing anxiety- or cancer-related neuropathy (200 for neuropathy and 200 for anxiety) and who had finished primary cancer treatment were invited to participate. Data were collected at 3 time points regardless of randomization condition: baseline, 8 weeks, and 16 weeks. Both face-to-face and web-based recruitment strategies were used. The trial was opened for 2 separate primary outcomes (anxiety- or cancer-related neuropathy). The goal was not to compare these groups but to compare treatment and waitlist groups for each condition. In addition to evaluating the impact of mobile mindfulness on reported anxiety- or cancer-related neuropathy, other pain, fatigue, trauma, sleep, and satisfaction with the Mindfulness Coach app will also be assessed.
Results: Outcomes of the study are expected in early 2024.
Conclusions: Mindfulness meditation has become widely practiced, and the use of mobile technology has become ubiquitous. Finding ways to deliver mindfulness meditation to people who have been treated for cancer allows for the intervention to be accessible to a larger number of survivors. The results of this intervention could have implications for further understanding the impact of mindfulness meditation on 2 persistent side and late effects of treatment of cancer, namely anxiety- and cancer-related neuropathy. CLINICALTRIAL ClinicalTrials.gov NCT03581357; https://ClinicalTrials.gov/study/NCT03581357 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/47745
Comparable studies
Other randomized controlled trials on anxiety, most cited first.
Citations in the library
Cites 8
- Using Self-Report Assessment Methods to Explore Facets of Mindfulness Assessment January 27, 2006
- Alterations in Brain and Immune Function Produced by Mindfulness Meditation Psychosomatic Medicine July 1, 2003
- A Randomized, Wait-List Controlled Clinical Trial: The Effect of a Mindfulness Meditation-Based Stress Reduction Program on Mood and Symptoms of Stress in Cancer Outpatients Psychosomatic Medicine September 1, 2000
- Mindfulness‐based stress reduction and attentional control Clinical Psychology & Psychotherapy November 1, 2007
- The Efficacy of Mindfulness-Based Interventions in Primary Care: A Meta-Analytic Review. Annals of family medicine November 1, 2015
and 3 more in the library